Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-001981

Options or other derivatives

  • Director acquired 40,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Garland J. Scott Director 2025-01-21 Grant or award · Common Stock +40,400 40,400 D
Loading xslF345X05/form4-01232025_110148.xml…